Silicon Therapeutics IPO

Silicon Therapeutics is a fully integrated drug design, research and development company focused on small molecule therapeutics. The company owns the entire spectrum of proprietary physics-driven drug discovery from chip-to-clinic.

Register for Details

For more details on financing and valuation for Silicon Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Silicon Therapeutics

Forge green plus iconForge green minus icon

When was Silicon Therapeutics founded?

Silicon Therapeutics was founded in 2016.
Updated on: Jun 12, 2022